Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q2 2024 · 10-Q
Revenue$9.58M$9.58M+7.3% vs Q2 2023 Net Income$794.34K$794.34KN/M vs Q2 2023 EPS Diluted$0.26$0.26N/M vs Q2 2023 Operating Income-$763,912N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$333,151N/M Margins · derivedOperating margin-8.0%+9.8 pt vs Q2 2023
Net margin8.3%+31.8 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 16, 2024 · 47 d after period end